Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chen Hermesh"'
Autor:
Michal Ayalon-Soffer, Ilan Tsarfaty, Judith Horev, Cylia Israel, Tania Pergam, Kobi Bahat, Rinat Vidal-Finkelstein, Sarit Glezer, Cynthia Koifman, Yair Peres, Liat Dassa, Dalit Landesman-Milo, Aviva Chen, Merav Beiman, Tal Handelsman, Hagit Amitai, Zurit Levine, Galit Rotman, Chen Hermesh, Anat Oren, Zohar Tiran
Supplementary Data from A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0728f510025c26a48d35acabf1a0990e
https://doi.org/10.1158/1078-0432.22439773
https://doi.org/10.1158/1078-0432.22439773
Autor:
Michal Ayalon-Soffer, Ilan Tsarfaty, Judith Horev, Cylia Israel, Tania Pergam, Kobi Bahat, Rinat Vidal-Finkelstein, Sarit Glezer, Cynthia Koifman, Yair Peres, Liat Dassa, Dalit Landesman-Milo, Aviva Chen, Merav Beiman, Tal Handelsman, Hagit Amitai, Zurit Levine, Galit Rotman, Chen Hermesh, Anat Oren, Zohar Tiran
Purpose: The Met receptor tyrosine kinase and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), are involved in a wide range of biological activities, including cell proliferation, motility, invasion, and angiogenesis. The HGF/SF-Met sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c10d80c720e452961ef711b5197f841
https://doi.org/10.1158/1078-0432.c.6517195
https://doi.org/10.1158/1078-0432.c.6517195
Autor:
Chrishan S. Samuel, Galit Rotman, Chen Hermesh, Daniele Bani, Ross A. D. Bathgate, Alessandro Pini, Assaf Wool, Arie Zauberman, Ronen Shemesh
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 335:589-599
Pulmonary fibrosis is a progressive and lethal lung disease characterized by accumulation of extracellular matrix and loss of pulmonary function. No cure exists for this pathologic condition, and current treatments often fail to slow its progression
Autor:
Jakob Vinten-Johansen, Galit Rotman, Liat Dassa, Hagit Niv, Gady Cojocaru, Caleb Rutledge, Yossi Cohen, Iris Hecht, Amir Toporik, Jiang Rong, Mauro Perretti, Merav Beiman, Arie Zauberman, Ronen Shemesh, André L. F. Sampaio, Chen Hermesh
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 328:426-434
Activation of the formyl-peptide receptor-like (FPRL) 1 pathway has recently gained high recognition for its significance in therapy of inflammatory diseases. Agonism at FPRL1 affords a beneficial effect in animal models of acute inflammatory conditi
Autor:
Merav Beiman, Tal Handelsman, Cylia Israel, Zohar Tiran, Kobi Bahat, Ilan Tsarfaty, Michal Ayalon-Soffer, Chen Hermesh, Yair Peres, Zurit Levine, Tania Pergam, Dalit Landesman-Milo, Aviva Chen, Anat Oren, Liat Dassa, Judith Horev, Galit Rotman, Hagit Amitai, Rinat Vidal-Finkelstein, Sarit Glezer, Cynthia Koifman
Publikováno v:
Clinical Cancer Research. 14:4612-4621
Purpose: The Met receptor tyrosine kinase and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), are involved in a wide range of biological activities, including cell proliferation, motility, invasion, and angiogenesis. The HGF/SF-Met sign
Publikováno v:
Journal of Molecular Biology. 285:609-625
Peptides derived from conserved heptad-repeat regions of several viruses have been shown recently to inhibit virus-cell fusion. To find out their possible role in the fusion process, two biologically active heptad-repeat segments of the fusion protei
Autor:
Ross A. D. Bathgate, Amit Novik, Yossi Cohen, Zurit Levine, Ronen Shemesh, Avi Rosenberg, Yossef Kliger, Assaf Wool, Amir Toporik, Chen Hermesh
Publikováno v:
Annals of the New York Academy of Sciences. 1160
In a screening effort based on algorithmic predictions for novel G-protein-coupled receptor (GPCR) peptide activators, we were able to identify and examine two novel peptides (P59 and P74) which are short, linear, and derived from a natural, previous